Boing Boing

Consortium for Plant Biotechnology Research rips off writer, threatens to sue ... Boing Boing But not in the case of The Consortium for Plant Biotechnology Research, Inc., a company that receives millions in federal grants to fund biotech research. When Purrington sent CPBR an email telling them off for plagiarizing him, they responded by ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFZV3b2GxSbuQzeeTODurA406m_gg&url=http://boingboing.net/2013/04/08/consortium-for-plant-biotechno.html

Canada NewsWire (press release)

Biotechnology Industry Leader Mark Lievonen Honoured Business Wire (press release) OTTAWA, Ontario--(BUSINESS WIRE)--On behalf of the biotechnology industry in Canada we congratulate Mark Lievonen, President of Sanofi Pasteur Limited for his recent induction to the Canadian Marketing Healthcare Hall of Fame Award, in recognition ... Sanofi Pasteur's Mark Lievonen Honoured For Commitment to Biotechnology ...Canada NewsWire (press release) all 11 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNH6xwxfISDloO5Y8ePqnfxWNHhcqA&url=http://www.businesswire.com/news/home/20130411006494/en/Biotechnology-Industry-Leader-Mark-Lievonen-Honoured

Dow AgroSciences Unveils Biotechnology Research Center Hoosier Ag Today Dow AgroSciences officially cut the ribbon on their new biotechnology research center. The 19 acre facility houses over 200 researchers working with some of the most sophisticated and up-to-date technology in the world, all with the goal of increasing ... Dow AgroSciences opens new facility at global headquartersR & D Magazine all 4 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNESU6iQca_7eXYCOQVqvgjlAW-VBA&url=http://www.hoosieragtoday.com/index.php/2013/04/10/dow-agrosciences-unveils-biotechnology-research-center/

Science of genome-sequencing has rocketed forward in 10 years Milwaukee Journal Sentinel Howard Jacob, who has directed the sequencing efforts as head of the Medical College's human and molecular genetics center, has begun seeking support for an ambitious $60 million institute that would include clinical and research programs, data storage ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGU25G4CfxIN9e82bVH0sm7ppAQ4A&url=http://www.jsonline.com/features/health/science-of-genomesequencing-has-rocketed-forward-in-10-years-0u9he1e-202852881.html

Telegraph.co.uk

Dutch and Russian universities set up stem cell research centre Telegraph.co.uk The 2012 Nobel Prize was awarded for the discovery that mature cells can be reprogrammed to become pluripotent (stem cells) by scientists in Japan and the UK ,and Skoltech has engaged one of the world's leading experts in cancer and molecular genetics ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEM36DMngvE870TwVnEp0_IrtSXrg&url=http://www.telegraph.co.uk/technology/news/9979659/Dutch-and-Russian-universities-set-up-stem-cell-research-centre.html

Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV ... Science Careers Blog (subscription) 1Department of Microbiology, Immunology and Molecular Genetics and the UCLA AIDS Institute, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA. 2Division of Pulmonary and Critical Care Medicine ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGXLSTRk1jf9ii2Aoog8d7Kbw7o8g&url=http://www.sciencemag.org/lookup/doi/10.1126/science.1235208

Harvard Gazette

Science under the stage lights Harvard Gazette The American Cancer Society Professor in the Department of Microbiology and Molecular Genetics at Harvard Medical School first fell in love with the art form during a production of Samuel Beckett's absurdist play “Waiting for Godot.” But it wasn't ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEu3Q9EAt3wqJXB2MWn6gMss4AF5Q&url=http://news.harvard.edu/gazette/story/2013/04/science-under-the-stage-lights/

Eureka! Science News

UCLA study suggests potential therapy for HIV Eureka! Science News ... they produce type-1 interferons, which trigger the immune system's protective defenses and sets off an alarm to notify surrounding cells," explained principal investigator David Brooks, assistant professor of microbiology, immunology and molecular ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHxKurbLBk3Vga0bMbJ4UxgqSOQcg&url=http://esciencenews.com/articles/2013/04/11/ucla.study.suggests.potential.therapy.hiv

The Future of Things

Food Supplement Could Help Delay Parkinsons Disease The Future of Things A team of researchers from the Department of Human Molecular Genetics and Biochemistry in the Tel Aviv University (TAU) led by Prof. Gil Ast and Dr. Ron Buchner and recently discovered that a supplement known as phosphatidylserine can improve the ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHFvOYMyvLlb2mZsBH5h2gcEfWmWw&url=http://thefutureofthings.com/news/11582/food-supplement-could-help-delay-parkinsons-disease.html

The stock price of StemCells, Inc.,
price today jumped as much as 9 percent after the company disclosed
it had finally concluded an agreement with the California stem cell
agency for a $19.3 million forgivable loan for research twice rejected by the agency's scientific reviewers..

"With CIRM's support, we are now
able to lay the groundwork that could result in the world's first
neural stem cell trial in Alzheimer's patients."

 “At this time, we
do not intend to elaborate any further on the contents of our press
releases or public filings pertaining to the SVB (Silicon Valley Bank) or CIRM(the stem cell agency) loans.”

“The matching  requires
them to demonstrate they have enough funds necessary to
fund SCI’s share going forward as well as their own
operations and other commitments.”

“Our goal is to always fund the best,
most promising science. This is not the first time that our board has
voted to fund a project that the Grants Review Group had not
recommended (this has happened in around 2% of cases) The board did
so for a number of reasons, not the least of which is that this was
the first disease team application that had a goal of  moving a
promising stem cell therapy for Alzheimer's towards clinical
trials.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/34J6wy7wpLY/stemcells-inc-nails-down-controversial.html

Of all California's newspapers, The
Sacramento Bee, the only daily paper in the state capital, has long
been the most critical – editorially – of the Golden State's $3
billion stem cell research agency.

“Stem cell agency finally addresses
potential for conflicts”

 “He hasn't
gone as far as we would like, or that independent outside reviewers
have recommended....But he's achieved what's possible, at least for
now, and the board may empower him to go further.”

“We
think Thomas and the oversight board should go further and adopt the
Institute of Medicine recommendations. But that is politically
unlikely. As is now obvious, it will be up to the Legislature to
fully remove representatives of funding-eligible institutions from
being involved in decisions about grants that could come back to
them.

“Thomas, to his credit, recognizes
that his compromise may not be the perfect solution. He wants to test
out the new policy for a year, and see how it works. There's a lot
riding on the outcome. CIRM is expected to run out of funds in 2017,
and while philanthropy and foundation money could extend that for a
few years, supporters of California stem cell research clearly want
to go back to the ballot to seek additional funding. To make that
case, CIRM supporters can't afford any more scandals about insider
dealing. The next year will reveal whether it is on the right track.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/NowG2d8N5CM/modest-approval-from-long-time-stem.html

Doctors, Patients Speak on Personal Experiences Vatican City, April 11, 2013 (Zenit.org) Junno Arocho Esteves | 380 hits

During todays first session of the Second International Vatican Adult Stem Cell Conference, scientists, doctors and patients had an opportunity to share not only the advances in adult stem cell research, but also the potential it has to transform modern day health care.

The ethical debate on the use of embryonic stem cells has, according to Dr. Robin Smith, stifled the advances made in adult stem cells, which are derived from adult tissue samples. Dr. Smith serves as president of the Stem for Life Foundation as well as CEO of NeoStem, a leading developer in cellular therapy.

Stem Cell Therapy, especially using cultivated adult stem cells , can be used to regenerate dying tissue in the body of a person suffering debilitating diseases, such as Alzheimers, Parkinsons, or Multiple Sclerosis (MS).

In November 2001, we kicked of the first Stem Cell Conference. Since then, the entire world has awakened.

By improving the clinical outcomes, we can save hundreds of millions of lives, she said. We're not talking about medications, she continued. Were talking about repairing the heart with adult stem cells. Re-inserting these cells into a damaged organ is turning back the clock. In just 17 months, we have seen stunning advancements in leukemia treatments.

The work in stem cell research has only begun to be understood. The last conference did not have panels that discussed the benefits of cellular therapy on MS and diabetes. Dr. Smith stated that in the United States, $245 billion is spent on managing diabetes, which can cause blindness, stroke and amputations which is only getting worse.

Cellular therapy has the potential to rewrite the history of this disease, she said. Adult stem cells is something we can all agree upon; they are ethically pure. We can grasp whats inside of us and introduce them into the body.

The purpose of the conference, she concluded, was meant to inspire change and to promote the truth and promise behind stem cell science. We hope to show that you no longer have to choose between science and faith.

In Search of Hope

Read more from the original source:
Vatican Conference Hopes to Promote Truth on Adult Stem Cell Therapy

Stem Cell Therapy Treatment for Limb Girdle Muscular Dystrophy by Dr Alok Sharma, Mumbai, India.
Stem Cell Therapy Treatment for Limb Girdle Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Power and movements in the finger...

By: neurogenbsi

Continued here:
Stem Cell Therapy Treatment for Limb Girdle Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. - Video

Stem Cell Therapy Treatment for Polymyositis by Dr Alok Sharma, Mumbai, India.
Stem Cell Therapy Treatment for Polymyositis by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1) Patient had a fall on 31st December 2012 due to whi...

By: neurogenbsi

Go here to read the rest:
Stem Cell Therapy Treatment for Polymyositis by Dr Alok Sharma, Mumbai, India. - Video

Stem Cell Therapy Treatment for Inclusive Body Myopathy by Dr Alok Sharma, Mumbai, India. Part 2

By: neurogenbsi

Continued here:
Stem Cell Therapy Treatment for Inclusive Body Myopathy by Dr Alok Sharma, Mumbai, India. Part 2 - Video

Stem Cell Therapy - Blue Horizon Stem Cells

By: Michael McDermott

The rest is here:
Stem Cell Therapy - Blue Horizon Stem Cells - Video

Performance After Adipose Stem Cell Therapy for Horse - Cash Fuez and Flaxey
Performance After Adipose Stem Cell Therapy for Horse - Cash Fuez and Flaxey http://wichitaequinevet.com "This is the video of Flaxey after he and Cash won t...

By: WichitaEquine

Read more:
Performance After Adipose Stem Cell Therapy for Horse - Cash Fuez and Flaxey - Video

U.S. News & World Report

Green Light to Genetic Engineering: The Monsanto Protection Act Center for Research on Globalization GMO foods and ingredients are toxic. They're unsafe to eat. Independent studies prove it. Monsanto and other agribusiness giants want all animal and vegetable life forms patented. They want worldwide food control. Obama's has promised GMO labeling. Why Do GMO's Need Protection?New York Times (blog) Opinion: Monsanto decision shows legislators' lazinessUConn Daily Campus all 76 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNES2wW0zCg51Y3AvtNNlyOHVT6GuQ&url=http://www.globalresearch.ca/the-monsanto-protection-act/5329439

Indian Express

Laser Therapy Switches Cocaine Addiction On, Off in Rats: Study U.S. News & World Report In this study, the researchers used genetic engineering to insert light-sensitive proteins called rhodopsins into nerve cells (neurons) in the rats' prefrontal cortex. Activating this brain region with a laser tuned to the rhodopsins turned the neurons ... Zapping away cocaine addiction with laser lightGizmag Lasers Zap Cocaine AddictionDiscovery News Laser Light Zaps Away Cocaine AddictionUCSF Today Science World Report all 47 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFSSIXKsTgIEVvmZfxF2T_Gqt9Q2g&url=http://www.usnews.com/health-news/news/articles/2013/04/03/laser-therapy-switches-cocaine-addiction-on-off-in-rats-study

The 9 Levels Of Healthcare / Biotechnology And Who Should Invest - Part 1 Seeking Alpha The 9 Levels Of Healthcare / Biotechnology And Who Should Invest - Part 1. Apr 5 2013, 17:29 by: Brian Nichols | includes: BMRN, BMY, JNJ, NVS, PCYC, REGN. It can be very confusing to navigate the healthcare sector, more specifically those companies in ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGvHqmd6SPecVUkWbzfS46F0XxU-Q&url=http://seekingalpha.com/article/1324331-the-9-levels-of-healthcare-biotechnology-and-who-should-invest-part-1?source%3Dgoogle_news